{
    "code": "01056767",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01056767",
    "time": "2021-10-29 08:19:26",
    "許可證字號": "衛署藥製字第056767號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/01\/11",
    "發證日期": "101\/01\/11",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00105676705",
    "中文品名": "&quot;晟德&quot;舒安敏內服液劑",
    "英文品名": "Levocetirizine Oral Solution &quot;CENTER&quot;",
    "適應症": "治療成人及六歲以上孩童因季節性過敏性鼻炎、常年性過敏性鼻炎、慢性蕁麻疹等所引起的各種過敏徵狀。",
    "劑型": "170內服液劑",
    "包裝": "4000毫升以下塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "LEVOCETIRIZINE DIHYDROCHLORIDE (EQ TO LEVOCETIRIZINE 2HCL)",
    "限制項目": "01國　產 26監視期滿新藥 61完成BE試驗",
    "申請商名稱": "1013806200  晟德大藥廠股份有限公司",
    "申請商地址": "台北市南港區園區街3之2號7樓",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400006810",
            "成分名稱": "LEVOCETIRIZINE DIHYDROCHLORIDE (EQ TO LEVOCETIRIZINE 2HCL)",
            "含量描述": "",
            "含量": "0.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "01056767001-104-12-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01056767&Seq=002&Type=9"
        },
        {
            "title": "舒安敏60ml標籤 20190627-108-11-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01056767&Seq=003&Type=8"
        },
        {
            "title": "01056767002-104-12-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01056767&Seq=002&Type=8"
        }
    ]
}